| IM | BI |
---|
Phase-A | 16/18 | 7/15 |
(89 %) | (47 %) |
Phase-B | 12/15 | 2/15 |
(80 %) | (13 %) |
- Plasma (Phase-A) or serum (Phase-B) samples of IM and BI treatments at 7 dpi analyzed. The values represent the number of positive samples/number of analyzed samples, and percentage of positive samples (in brackets)